More Evidence for SGLT2 Inhibitors in Heart Failure.

Tytuł:: More Evidence for SGLT2 Inhibitors in Heart Failure.
Autorzy:: Jarcho JA
Źródło:: The New England journal of medicine [N Engl J Med] 2020 Oct 08; Vol. 383 (15), pp. 1481-1482. Date of Electronic Publication: 2020 Aug 28.
Typ publikacji:: Editorial; Comment
Język:: English
Imprint Name(s):: Original Publication: Boston, Massachusetts Medical Society.
MeSH Terms:: Heart Failure*
Sodium-Glucose Transporter 2 Inhibitors*
Benzhydryl Compounds ; Glucosides ; Humans
Substance Nomenclature:: 0 (Benzhydryl Compounds)
0 (Glucosides)
0 (Sodium-Glucose Transporter 2 Inhibitors)
HDC1R2M35U (empagliflozin)
Entry Date(s):: Date Created: 20200901 Date Completed: 20201009 Latest Revision: 20201009
Update Code:: 20240105
DOI:: 10.1056/NEJMe2027915
PMID:: 32865378
: Opinia redakcyjna

Comment on: N Engl J Med. 2020 Oct 8;383(15):1413-1424. (PMID: 32865377)

Informacja